Zhenchang Y. Sun

No. 1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Prognostic significance of Ki-67 in grade 3A follicular lymphoma and development of a novel PFS nomogram.

Prognostic significance of Ki-67 in grade 3A follicular lymphoma and development of a novel PFS nomogram.

Journal: Annals of hematology
Published: December 18, 2025

A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.

A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.

Journal: Cancer
Published: September 19, 2025

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Journal: Therapeutic advances in medical oncology
Published: September 04, 2025

ABO Blood Group and the Risk and Prognosis of Diffuse Large B-Cell Lymphoma.

ABO Blood Group and the Risk and Prognosis of Diffuse Large B-Cell Lymphoma.

Journal: Cancer management and research
Published: March 31, 2025

Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.

Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.

Journal: Journal of translational medicine
Published: October 29, 2024

Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway.

Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway.

Journal: Gut
Published: August 03, 2024

TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL.

TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL.

Journal: Scientific reports
Published: April 10, 2024

The relationship and clinical significance of serum cytokine expression level and skin pruritus in patients with Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma.

The relationship and clinical significance of serum cytokine expression level and skin pruritus in patients with Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma.

Journal: International immunopharmacology
Published: October 20, 2023

Elucidating osseointegration in vivo in 3D printed scaffolds eliciting different foreign body responses.

Elucidating osseointegration in vivo in 3D printed scaffolds eliciting different foreign body responses.

Journal: Materials today. Bio
Published: May 31, 2023

Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.

Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.

Journal: Leukemia & lymphoma
Published: January 19, 2023

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.

Journal: Cancer medicine
Published: September 09, 2022

Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma.

Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma.

Journal: Gut
Published: July 11, 2022
Showing 1-12 of 81

Last Updated: 09/26/2026